Limitation and coping strategies of anti-neoplasic angiogenesis therapy
10.3760/cma.j.issn.1673-422X.2010.11.011
- VernacularTitle:抗肿瘤新生血管生成治疗的局限及应对策略
- Author:
Yong LIU
;
Yabing MA
- Publication Type:Journal Article
- Keywords:
Neoplasms;
Angiogenesis inhibitors;
Neoplasm metastasis
- From:
Journal of International Oncology
2010;37(11):835-837
- CountryChina
- Language:Chinese
-
Abstract:
Anti-neoplasic angiogenesis therapy is a rising new treatment model for cancer in recent years, and it has been established the status of first-line treatment in the relevant anti-neoplasic fields. With the extensive clinical applications, the anti-neoplasic angiogenesis therapy have gradually showed some of its limitations and shortcomings,such as drug resistance, uncertain therapeutic window, lack of effective biomarkers, et al. However, we can overcome these disadvantages through combined chemotherapy, reasonable chemotherapy protocols and anti-VM therapy.
